Haemonetics HAE Income Statement (2009-2026)

NYSE HAE
$100.90 -2.26 (-2.19%)
As of: Sep 10, 2026 · 2:04 PM EDT
Reported Financials

Haemonetics Quarterly Income Statement

Periods 69 quarters
Latest Jun 2026

Haemonetics reported revenue of $339.38M and net income of $33.01M for the quarter ended Jun 2026, up 5.6% year over year. This income statement covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2009 Sep2009 Dec2009 Apr2010 Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
239.90M259.77M265.00M261.46M297.49M305.30M304.42M311.33M318.18M336.25M343.29M336.17M345.51M348.54M330.60M321.39M327.31M338.97M346.35M339.38M
Cost of RevenueCost of Rev
117.36M121.20M128.69M119.19M139.61M146.59M148.17M144.07M147.67M158.38M167.38M161.25M158.07M155.00M137.55M129.15M132.57M136.58M148.14M136.58M
Gross Profit
122.54M138.56M136.31M142.26M157.88M158.71M156.25M167.26M170.51M177.87M175.91M174.92M187.44M193.55M193.05M192.24M194.74M202.39M198.21M202.80M
Operating items
Amortization - Intangibles
11.40M12.15M11.48M8.37M8.22M8.08M7.97M7.47M7.22M6.91M10.43M12.47M12.26M12.23M11.30M11.39M11.18M10.93M10.49M10.20M
Research & DevelopmentR&D
10.85M10.04M13.21M10.90M10.90M12.69M15.64M12.65M12.66M13.27M15.86M14.45M14.14M15.83M18.30M16.26M14.87M14.19M14.45M16.20M
Selling, General & AdministrativeSG&A
75.78M80.73M92.42M92.23M92.03M94.66M97.76M93.48M115.32M111.71M109.26M108.25M106.95M106.46M115.14M110.72M101.61M109.15M120.93M118.94M
Other Operating ExpensesOther Opex
0.38M7.47M7.22M6.91M20.84M12.47M14.65M12.23M-11.73M11.39M19.77M11.65M85.86M10.20M
Operating ExpensesOpex
98.03M102.91M117.11M111.50M111.15M115.43M120.99M113.61M135.21M131.89M145.96M135.17M135.74M134.52M121.72M138.37M136.25M134.99M221.24M145.34M
Operating IncomeOp. Inc
24.51M35.65M19.20M30.77M46.73M43.28M35.26M53.66M35.30M45.98M29.94M39.76M51.70M59.03M71.33M53.87M58.49M67.40M-23.02M57.46M
EBIT
24.51M35.65M19.20M30.77M46.73M43.28M35.26M53.66M35.30M45.98M29.94M39.76M51.70M59.03M71.33M53.87M58.49M67.40M-23.02M57.46M
Non-operating items
Non Operating Interest Expenses
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
-4.59M-4.26M-3.87M-5.27M-5.67M-1.05M-2.63M-2.07M-2.47M-1.95M-6.53M6.96M-6.99M-9.11M-0.60M-8.70M-7.21M-7.42M-5.37M-9.88M
Net income details
EBT
19.92M31.39M15.33M25.49M41.06M42.22M32.63M51.59M32.83M44.03M23.41M46.71M44.70M49.92M70.74M45.17M51.28M59.98M-28.40M47.57M
Tax ProvisionsTaxes
5.10M8.20M5.55M5.62M7.90M9.30M3.20M10.55M7.92M12.80M3.01M8.34M10.90M12.42M12.76M11.14M12.60M15.23M-8.28M14.60M
Profit After TaxPAT
14.86M23.42M9.54M19.88M33.20M37.40M29.38M41.04M24.91M39.56M14.37M38.37M33.83M37.49M57.98M34.03M38.68M44.74M-20.15M33.01M
Income from Continuing OperationsIncome (Continuing)
14.82M23.19M9.77M19.88M33.16M32.92M29.42M41.04M24.91M31.23M20.41M38.37M33.80M37.49M57.98M34.03M38.68M44.74M-20.12M32.97M
Consolidated Net IncomeConsol Net Inc.
14.82M23.19M9.77M19.88M33.16M32.92M29.42M41.04M24.91M31.23M20.41M38.37M33.80M37.49M57.98M34.03M38.68M44.74M-20.12M32.97M
Income towards Parent CompanyParent Net Inc
14.82M23.19M9.77M19.88M33.16M32.92M29.42M41.04M24.91M31.23M20.41M38.37M33.80M37.49M57.98M34.03M38.68M44.74M-20.12M32.97M
Net Income towards Common StockholdersNet Income
14.82M23.19M9.77M19.88M33.16M32.92M29.42M41.04M24.91M31.23M20.41M38.37M33.80M37.49M57.98M34.03M38.68M44.74M-20.12M32.97M
Additional items
EPS (Basic)
0.290.450.190.390.650.650.580.810.490.620.400.750.660.751.150.710.810.96-0.430.73
EPS (Diluted)
0.290.450.190.380.640.640.570.800.480.610.400.740.660.741.140.700.810.95-0.420.72
Shares Outstanding
51.04M51.09M51.05M51.22M50.95M50.51M50.78M50.54M50.73M50.77M50.71M50.94M50.90M50.29M50.33M48.11M47.59M46.79M47.18M45.36M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
51.46M51.34M51.35M51.68M51.56M51.22M51.42M51.34M51.40M51.45M51.40M51.56M51.24M50.64M50.73M48.35M47.66M46.99M47.35M45.70M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
51.06M51.11M51.12M51.32M50.61M50.44M50.45M50.71M50.74M50.79M50.79M51.15M50.38M50.24M48.22M48.16M46.75M46.83M45.25M45.47M
EBITDA
24.51M35.65M19.20M30.77M46.73M43.28M35.26M53.66M35.30M45.98M29.94M39.76M51.70M59.03M71.33M53.87M58.49M67.40M-23.02M57.46M
Interest ExpensesInt Expense
Tax Rate
25.60%26.12%36.24%22.03%19.24%22.03%9.81%20.45%24.13%29.07%12.84%17.85%24.38%24.89%18.03%24.66%24.57%25.40%29.15%30.69%